Showing Results for: “Glycemic Index and Diabetes”

Senate Reconciliation Bill Would Reduce the Price of Insulin Today, Senate Democrats, including Senate Diabetes Caucus Co-Chair Sen. Jeanne Shaheen (D-NH), announced potential updates to the Inflation Reduction Act, which was released earlier this week. The Senate bill could now include a $35 monthly cap on out-of-pocket costs for insulin, and it could also allow Medicare to directly negotiate the price of insulin products with drug manufacturers. The American Diabetes Association® (ADA) has been the leading advocate for insulin copay caps across the country, resulting in the enactment of

Leading Diabetes Scientific Sessions Meeting Brings Together Researchers From Around the World With Hybrid Format Today, the American Diabetes Association ® (ADA) kicks off the 82nd Scientific Sessions in New Orleans, LA. The ADA’s Scientific Sessions is the world’s premier meeting in diabetes with a broader reach than ever with hybrid options for attendees. The meeting will take part live and virtually from around the globe today, June 3, through June 7 at the Ernest N. Morial Convention Center, presenting the latest cutting-edge advances in diabetes research, prevention, and care. This year

American Heart Association ® and American Diabetes Association ® reveal results of Know Diabetes by Heart ™ survey and share practical tips for staying on track with health goals through the holiday season Nearly half (49%) of people living with type 2 diabetes said managing their condition during a typical fall and winter holiday season is more difficult than other times of the year, according to a new survey for the American Heart Association and American Diabetes Association. The online survey of more than 1,000 U.S. adults 45 and older completed by real-time market research platform

The American Diabetes Association ® applauds last week’s ruling by Florida’s Second Circuit Court striking down Florida Governor DeSantis’ Executive Order banning local school boards from implementing mask mandates. The decision held that school districts can adopt health care policies over parental disagreements. The Judge referenced two Florida Supreme Court decisions supporting limiting individual rights when impacting the rights of others. The Judge further stated that the governor’s and state agencies’ actions in banning mask mandates don’t pass “Constitutional muster.” Attending school

New study points to diabetes management as critical factor in improving patient outcomes during pandemic outbreaks Findings of a new study show diabetes was the main risk factor for the accelerated advancement to a severe state in Japanese COVID-19 patients. Results of the retrospective analysis were presented at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Throughout the pandemic, diabetes has persisted as a significant risk factor for COVID-19. In hospitalized patients with diabetes and COVID-19, one in 10 people die within seven days of admission

For 74 years, National Summer Camps Have Equipped Children with Diabetes and Their Families with Diabetes Management Tools in Safe and Fun-Filled Environment Registration is open for the American Diabetes Association ® (ADA) 2023 summer camp season. The ADA runs 33 camps located in 20 states throughout the summer season, June through August. ADA camps provide a medically safe environment where children with diabetes and their families can partake in a fun-filled summer camp experience while learning how to better manage diabetes. ADA camps also serve as a connecting point for children to

Insulin Price Reduction Act, Safe Step Act, and Chronic Condition Copay Elimination Act are first bills analyzed and supported by ADA’s newly launched Advocacy Engagement Platform The American Diabetes Association (ADA) announced formal endorsement of three bills aiming to reduce the high cost of insulin and prescription drugs: the Insulin Price Reduction Act, the Safe Step Act, and the Chronic Condition Copay Elimination Act. The three bills were analyzed using ADA’s newly launched Engagement Platform . The Insulin Price Reduction Act (H.R.4906/S.2199) will reduce the skyrocketing cost of

Study presented at ADA’s Scientific Sessions compared insulin-only mode of iLet to usual care The iLet bionic pancreas (BP)¹ significantly increased the percentage of time adults with type 1 diabetes (T1D) had glucose levels between 70–180 mg/dl, when compared to usual care (UC) therapy of either multiple daily insulin injections (MDI) or continuous subcutaneous insulin infusion (CSII), according to the study, “First Human Study Testing the iLet, a Purpose-Built Bionic Pancreas Platform,” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone

Children with early-onset type 1 diabetes (T1D) and poor glycemic control have slower growth of areas in the brain associated with mild cognitive deficits compared to children without diabetes, according to the study, “ADA Presidents' Select Abstract: Type 1 Diabetes and the Developing Brain—A Longitudinal Study of Brain Growth by the Diabetes Research in Children Network (DirecNet),” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. The study found that children with early-onset T1D have mild but

Pancreatic beta cells that do not produce sufficient insulin in people with type 2 diabetes (T2D) are not permanently damaged during the early stages of the disease and can be restored to normal function through the removal of excess fat in the cells, according to a study entitled “Remission of Type 2 Diabetes for Two Years Is Associated with Full Recovery of Beta-Cell Functional Mass in the Diabetes Remission Clinical Trial (DiRECT)” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions®. More than one-third (36%) of the participants who took part in an